Micro
Emerging
Active
AstraZeneca faces no material risk from Daiichi supply review
New narrative with limited coverage — still forming.
Score
0.5
Velocity
▲ 1.0
Articles
1
Sources
1
Sentiment Timeline
Event Timeline
Timeline
Last UpdatedApr 28, 2026